Levamisole and mebendazole in the treatment of bancroftian infection.
dc.contributor.author | Narasimham, M V | en_US |
dc.contributor.author | Roychowdhury, S P | en_US |
dc.contributor.author | Das, M | en_US |
dc.contributor.author | Rao, C K | en_US |
dc.date.accessioned | 2009-05-27T15:19:58Z | |
dc.date.available | 2009-05-27T15:19:58Z | |
dc.date.issued | 1978-12-01 | en_US |
dc.description | The Southeast Asian Journal of Tropical Medicine and Public Health. | en_US |
dc.description.abstract | Levamisole and mebendazole, broad spectrum anthelminthic compounds were tested against microfilaria of Wuchereria bancrofti, and the results were compared with similarly treated diethylcarbamazine and untreated group. Levamisole at a dosage of 3 mg/kg daily for 8 days showed marked reduction in both microfilaria rate and microfilaria density and immediately thereafter mf-rate steadily increased almost up to pre-treatment level, the mf-density however showed only marginal increase. Mebendazole at dosage of 6 mg/kg daily for 10 days following 8 days treatment of levamisole also showed marginal increase of mf-rate but no increase of mf-density. Treatment with DEC at a dosage of 6 mg/kg daily for 12 days showed comparatively better results both in respect of reduction in mf-rate and mf-density. The reactions - severity and duration were more among levamisole treated groups as compared to DEC treated group. Thus with the dosages tried, DEC could be considered as a better drug than levamisole and mebendazole. Both the latter compounds had no or very limited effect on the adult worms of W. bancrofti. | en_US |
dc.identifier.citation | Narasimham MV, Roychowdhury SP, Das M, Rao CK. Levamisole and mebendazole in the treatment of bancroftian infection. The Southeast Asian Journal of Tropical Medicine and Public Health. 1978 Dec; 9(4): 571-5 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/32515 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.tm.mahidol.ac.th/seameo/publication.htm | en_US |
dc.subject.mesh | Benzimidazoles --therapeutic use | en_US |
dc.subject.mesh | Diethylcarbamazine --therapeutic use | en_US |
dc.subject.mesh | Filariasis --drug therapy | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Levamisole --adverse effects | en_US |
dc.subject.mesh | Mebendazole --therapeutic use | en_US |
dc.subject.mesh | Placebos | en_US |
dc.subject.mesh | Wuchereria bancrofti | en_US |
dc.title | Levamisole and mebendazole in the treatment of bancroftian infection. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Controlled Clinical Trial | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1